TRCT
RXST icon

Tower Research Capital (TRC)’s RxSight RXST Stock Holding History

Tower Research Capital (TRC)’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.2K Buy
4,818
+621
+15% +$3.75K ﹤0.01% 3420
2026
Q1 		$25.9K Sell
4,197
-1,012
-19% -$8.4K ﹤0.01% 3298
2025
Q4 		$54.3K Buy
5,209
+195
+4% +$1.96K ﹤0.01% 2355
2025
Q3 		$45.1K Sell
5,014
-560
-10% -$4.92K ﹤0.01% 2610
2025
Q2 		$72.5K Buy
5,574
+3,398
+156% +$51.1K ﹤0.01% 2650
2025
Q1 		$54.9K Buy
2,176
+821
+61% +$24.4K ﹤0.01% 2168
2024
Q4 		$46.6K Sell
1,355
-1,169
-46% -$52.7K ﹤0.01% 2603
2024
Q3 		$125K Sell
2,524
-2,739
-52% -$140K ﹤0.01% 2059
2024
Q2 		$317K Buy
5,263
+5,052
+2,394% +$289K 0.01% 1720
2024
Q1 		$10.9K Sell
211
-1,263
-86% -$62K ﹤0.01% 3633
2023
Q4 		$59.4K Sell
1,474
-1,572
-52% -$46.1K ﹤0.01% 3016
2023
Q3 		$85K Buy
3,046
+2,703
+788% +$80.6K ﹤0.01% 2101
2023
Q2 		$9.88K Sell
343
-220
-39% -$4.89K ﹤0.01% 4202
2023
Q1 		$9K Sell
563
-168
-23% -$2.37K ﹤0.01% 4536
2022
Q4 		$9K Sell
731
-444
-38% -$5.4K ﹤0.01% 4251
2022
Q3 		$14K Buy
1,175
+171
+17% +$2.35K ﹤0.01% 4224
2022
Q2 		$14K Sell
1,004
-24
-2% -$317 ﹤0.01% 4163
2022
Q1 		$13K Sell
1,028
-982
-49% -$11.8K ﹤0.01% 3998
2021
Q4 		$23K Buy
2,010
+1,333
+197% +$16K ﹤0.01% 3525
2021
Q3 		$9K Buy
+677
New +$9.32K ﹤0.01% 4465

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Tower Research Capital (TRC)'s RXST Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its RxSight (RXST) stake by 15% in Q2 2026, buying an estimated $3.75K and bringing the position to 4,818 shares worth $23.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3420.

Tower Research Capital (TRC) first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $317K in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Tower Research Capital (TRC) held 4,818 shares of RxSight worth $23.2K as of Q2 2026.
  • Tower Research Capital (TRC) bought 621 RxSight shares in Q2 2026, an estimated $3.75K.
  • RxSight made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3420 holding.
  • Tower Research Capital (TRC) first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s RxSight position peaked at $317K in Q2 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.